Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumors Harboring the KRAS G12C Mutation

Explore clinical trials studying Advanced Solid Tumors Harboring the KRAS G12C Mutation. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Advanced Solid Tumors Harboring the KRAS G12C Mutation trial results

Recruiting

Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments

NCT07468071

Conditions
Advanced Solid Tumors Harboring the KRAS G12C Mutation, Bronchial Neoplasms, Carcinoma, Bronchogenic, +18 more
Locations
  • Novartis Investigative Site Sint-Niklaas, Oost Vlaanderen, Belgium
  • Novartis Investigative Site Montreal, Quebec, Canada
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Kashiwa, Chiba, Japan
View Trial Details

Related conditions